The federal government is reportedly going after an apartment company with thousands of rental properties in metro Atlanta.
The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.
The suit accuses the company of falsely advertising rental prices by failing to inform renters of numerous mandatory fees.
Representative Ben Cline (R-VA) says the One Agency Act would house all antitrust authority under the Department of Justice. ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...
The health-care sector has been rebounding recently following a sharp selloff in recent weeks amid hopes that controversy would die down. The health-care industry group was among the leading S&P 500 ...
A report from the Federal Trade Commission (FTC) has determined that pharmacy benefit managers (PBMs) are linked to significant cost increases for cancer, HIV, and other critical specialty drugs.
The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
Oblivion remake, reported to be in the works and set for release in 2025, has seen an alleged list of details leak onto the ...
After announcing a settlement last year, the FTC is now sending refund checks to 6,700+ consumers who bought Razer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback